Xiaodong Li’s Post

The early bird pricing for the American Conference Institute's 22nd Advanced Summit on Life Science Patents expires THIS FRIDAY - take advantage! 2024 conference highlights include: - Establishing sound and successful protocols to procure and enforce life sciences patents in the U.S. and internationally - Mastering the art of claim balance and disclosure, drawing on lessons from patents and cases in the year post-Amgen v Sanofi - Re-evaluating the “pros and cons” of opting-into the EU’s Unitary Patent system, including a discussion of the first preliminary injunction granted by the Unified Patent Court (UPC) - And so much more! Details here: https://lnkd.in/dGZkuGWK #ACIConferences #lifesciences #patents #intellectualproperty

Today, the European Patent Institute epi published its Position Paper on NGT Plant Patenting Proposal of the European Parliament here and on linkedin.  epi expresses significant concerns regarding the proposed exclusion of plants from patentability which was inserted by way of amendments into the pending proposal of Regulation of the European Parliament and of the Council on plants obtained by certain new genomic techniques. epi strongly advocates for the necessity of conducting a thorough impact study before any legislative measures are considered. See more information on https://lnkd.in/eCBPNs5F. In case of any further questions, do not hesitate to contact our experts on [email protected].  #Patentability #PlantInnovation #RegulationImpactStudy #EPO #IntellectualProperty #PatentLaw #Patents #FromIdeatoIP

Communication under Rule 71(3) EPC European Patent Office intention to grant us a diagnostic and therapeutic treatment patent. This gives us very high degree of freedom to operate in with orally active first-in-class compounds. Text read, “You are informed that the examining division intends to grant a European patent on the basis of the above application, with the text and drawings and the related bibliographic data as indicated below.” Great to get approval on Preeclampsia Awareness Day. #PreeclampsiaAwareness

The battle to claim the earliest valid patent rights to CRISPR gene-editing technology has been fought around the world. In Australia, the most protracted dispute to date has focussed on priority rights of patent application AU2013335451, filed in October 2013 by South Korean biotech company, ToolGen Incorporated. This dispute has now come to an end, with ToolGen applying to amend the patent claims to overcome the Court’s earlier invalidity finding, including to correct an alleged “obvious mistake”. Read more: https://lnkd.in/gZzRtgXf #ipupdate #australiapatent #auslaw #patentprosecution #intellectualproperty #patentlaw #patent #australianpatent #pearceip #boutiquelawfirm

Do your claims measure up? Murgitroyd's Paul Andrews explores what some of the pitfalls are when using parameters in patent applications at the EPO. Read it here - https://lnkd.in/e6Kwx78U #EPO #patentapplication #patent #chemistrypatent #EPOparameters

The U.S. International Trade Commission (ITC) has issued a final determination of "no violation" for our client Gator Bio in a patent case related to biolayer interferometry products used in medical research. https://bit.ly/4eOVDCK The Perkins Coie team that successfully represented Gator Bio was led by Hari Santhanam and included Veronica Ascarrunz, Evan Day, Hessam Gharaviram, Michelle Yocum, Jim Valentine, and Bingjie Li. #Patents #PatentLitigation #PatentLaw #IPlaw

WIPO member states yesterday approved a groundbreaking new Treaty related to intellectual property (IP), genetic resources and associated traditional knowledge, marking a historic breakthrough that capped decades of negotiations. What Does the Treaty Do? Broadly, where a claimed invention in a patent application is based on genetic resources, each contracting party shall require applicants to disclose the country of origin or source of the genetic resources. Where the claimed invention in a patent application is based on traditional knowledge associated with genetic resources, each contracting party shall require applicants to disclose the Indigenous Peoples or local community, as applicable, who provided the traditional knowledge. #IP #WIPO #New_treaty #Traditional_knowledge #Genetic_Resources

RSM US LLP senior life sciences analysts Justin Culbertson and Brian Winne's recent industry outlook dive into how patent expirations could lead large biopharmas to invest in the middle market as they renew their patent pipelines. Read more:

An intellectual property trial team secured a complete victory before the U.S. International Trade Commission for client Gator Bio in a case related to biolayer interferometry products. The team prevailed on noninfringement and lack of technical domestic industry on multiple independent grounds. Learn more: https://bit.ly/4ceGMQn. #PatentLitigation #PatentLaw #IntellectualProperty

In Life Sciences IP Review’s latest article, Carpmaels & Ransford Partner Anna Leathley, Senior Associate Richard Newell and Associate Sarah Mitchell look at the UPC’s capacity for an uptick in life sciences litigation. The article below discusses potential pressure points regarding the capacity of the UPC system and how the court may manage these. #UPC #LifeSciences #Litigation https://lnkd.in/gumc7b7K